As a featured company sponsor, Merz will host a symposium, โ€œFacial Rejuvenation: Interactive Sessions to Level-Up Your Injection Skillsโ€ on February 1.

Data on the Merz Aesthetics product portfolio, including Belotero, Cellfina, and Radiesse is being featured in oral and poster presentations at the 2020 International Master Course on Aging Science (IMCAS) World Congress, now thru Saturday, February 1 in Paris, France.

In addition to the poster presentations, Merz Aesthetics will facilitate the symposium event โ€œFacial Rejuvenation: Interactive Sessions to Level-Up Your Injection Skillsโ€,to be held Saturday, February 1, from 10:30 am to 12:30 pm in the Amphi Bleu room.

Bob Rhatigan, chief executive officer of Merz Aesthetics will open the session, which includes treatment insights from international expert speakers, Tatjana Pavicic, MD (Dermatologist, Germany); Kate Goldie, MBChB (Aesthetic Physician, United Kingdom); Professor Yana Yutskovskaya, MD (Dermatologist, Russia); and Jani van Loghem, MD (Aesthetic Physician, Netherlands).

โ€œThis meeting provides a platform for Merz Aesthetics to not only foster education and continuous training but also, to engage in thoughtful industry conversations while connecting with medical aesthetics physicians and fellow industry leaders from around the world,โ€ says Rhatigan. โ€œWe are grateful that our heritage and innovation in this space allows us to partner with world-renowned medical aesthetic experts, to share research on the diversified Merz Aesthetics product portfolio at the IMCAS World Congress.โ€

In celebration of the companyโ€™s ten-year milestone launch of BOCOUTURE (incobotulinumtoxin A) in Europe, Thomas Rappl, MD, presented a booth talk on Friday about โ€œBOCOUTURE: 10 Years of a Unique Neurotoxin.โ€ The botulinum toxin is part of the Merz Aesthetics portfolio and has received approval in 15 countries in Europe within the last ten years.

To view the schedule of events, visit 2020 IMCAS World Congress online.